519 related articles for article (PubMed ID: 23340605)
21. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of tetracationic arene ruthenium metalla-cycles.
Barry NP; Edafe F; Therrien B
Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364
[TBL] [Abstract][Full Text] [Related]
24. Influence of PPh₃ moiety in the anticancer activity of new organometallic ruthenium complexes.
Sáez R; Lorenzo J; Prieto MJ; Font-Bardia M; Calvet T; Omeñaca N; Vilaseca M; Moreno V
J Inorg Biochem; 2014 Jul; 136():1-12. PubMed ID: 24690555
[TBL] [Abstract][Full Text] [Related]
25. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
26. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
28. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
[TBL] [Abstract][Full Text] [Related]
29. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
[TBL] [Abstract][Full Text] [Related]
30. Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
Rafols L; Josa D; Aguilà D; Barrios LA; Roubeau O; Cirera J; Soto-Cerrato V; Pérez-Tomás R; Martínez M; Grabulosa A; Gamez P
Inorg Chem; 2021 Jun; 60(11):7974-7990. PubMed ID: 33979132
[TBL] [Abstract][Full Text] [Related]
31. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure, and antiproliferative activity of ruthenium(II) arene complexes with N,O-chelating pyrazolone-based β-ketoamine ligands.
Pettinari R; Marchetti F; Pettinari C; Petrini A; Scopelliti R; Clavel CM; Dyson PJ
Inorg Chem; 2014 Dec; 53(24):13105-11. PubMed ID: 25412203
[TBL] [Abstract][Full Text] [Related]
33. Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
Clavel CM; Păunescu E; Nowak-Sliwinska P; Griffioen AW; Scopelliti R; Dyson PJ
J Med Chem; 2015 Apr; 58(8):3356-65. PubMed ID: 25812075
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
Savić A; Dulović M; Poljarević JM; Misirlić-Denčić S; Jovanović M; Bogdanović A; Trajković V; Sabo TJ; Grgurić-Šipka S; Marković I
ChemMedChem; 2011 Oct; 6(10):1884-91. PubMed ID: 21805645
[TBL] [Abstract][Full Text] [Related]
35. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
[TBL] [Abstract][Full Text] [Related]
37. A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathione.
Purkait K; Karmakar S; Bhattacharyya S; Chatterjee S; Dey SK; Mukherjee A
Dalton Trans; 2015 Apr; 44(13):5969-73. PubMed ID: 25742181
[TBL] [Abstract][Full Text] [Related]
38. Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene)Ru(curcuminato)chloro.
Caruso F; Rossi M; Benson A; Opazo C; Freedman D; Monti E; Gariboldi MB; Shaulky J; Marchetti F; Pettinari R; Pettinari C
J Med Chem; 2012 Feb; 55(3):1072-81. PubMed ID: 22204522
[TBL] [Abstract][Full Text] [Related]
39. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
[TBL] [Abstract][Full Text] [Related]
40. Arene Ruthenium(II) Complexes Bearing the κ-
Arlt S; Petković V; Ludwig G; Eichhorn T; Lang H; Rüffer T; Mijatović S; Maksimović-Ivanić D; Kaluđerović GN
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
